Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC
McGuire Institute
Salzburger Landeskliniken
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Alpha Tau Medical LTD.
Radboud University Medical Center
UNICANCER
University of Arkansas
Sanford Health
Karolinska University Hospital
Washington University School of Medicine
Leap Therapeutics, Inc.
CMR Surgical Ltd
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Arizona
M.D. Anderson Cancer Center
Galderma R&D
Revolution Medicines, Inc.
Regeneron Pharmaceuticals
University of Pittsburgh
Intensity Therapeutics, Inc.
UNICANCER
Sarcoma Oncology Research Center, LLC
The Center for Clinical and Cosmetic Research
University of Pittsburgh
Federation Francophone de Cancerologie Digestive
UNC Lineberger Comprehensive Cancer Center
National Taiwan University Hospital
UNC Lineberger Comprehensive Cancer Center
University of Arizona
University of Arizona
Merck Sharp & Dohme LLC
University of Pittsburgh
University of Oxford
Federation Francophone de Cancerologie Digestive
Cairo University
Advaxis, Inc.
Advaxis, Inc.
Rigshospitalet, Denmark
UNC Lineberger Comprehensive Cancer Center
Innovent Biologics (Suzhou) Co. Ltd.
Memorial Sloan Kettering Cancer Center
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.